| Research Directory
저자명 | 구분 | 논문제목 | ISSN | IF | 발행일자 |
---|---|---|---|---|---|
송진우 | SCIE | Sarcoid-like reaction in patients with malignant tumors: Long-term clinical course and outcomes | 2296-858X | 2022-08-17 | |
이상민 | SCIE | Characteristics and outcomes of anterior mediastinal cystic lesions diagnosed on chest MRI: implications for management of cystic lesions | 1869-4101 | 2022-08-17 | |
이창환 | SCIE | Lamin-A/C Is Modulated by the Involvement of Histamine-Mediated Calcium/Calmodulin-Dependent Kinase II in Lung Cancer Cells | 1422-0067 | 2.598 | 2022-08-13 |
정석훈 | SSCI | Applicability and Psychometric Comparison of the General-Population Viral Anxiety Rating Scales among Healthcare Workers in the COVID-19 Pandemic | 1660-4601 | 2022-08-12 | |
이필형 | SCIE | Incidence and predictors of intracranial bleeding after coronary artery bypass graft surgery | 2297-055X | 5.848 | 2022-08-12 |
심태선 | SCIE | Treatment outcomes of multidrug-resistant tuberculosis with chronic kidney/liver disease | 0903-1936 | 5.895 | 2022-08-10 |
정석훈 | SCIE | Validation of the Korean Version of the Positive and Negative Sleep Appraisal Measure (PANSAM) as a Tool for Evaluating Dysfunctional Beliefs about Sleep among the General Population | 2077-0383 | 2022-08-10 | |
박덕우 | SCIE | Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. | 0009-7322 | 14.739 | 2022-08-09 |
안정민 | SCIE | Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. | 0009-7322 | 14.739 | 2022-08-09 |
양동현 | SCIE | Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. | 0009-7322 | 14.739 | 2022-08-09 |
박한빛 | SCIE | Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. | 0009-7322 | 39.922 | 2022-08-09 |
윤성철 | SCIE | Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. | 0009-7322 | 14.739 | 2022-08-09 |
이재홍 | SCIE | Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. | 0009-7322 | 14.739 | 2022-08-09 |
김경원 | SCIE | Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. | 0009-7322 | 14.739 | 2022-08-09 |
김대희 | SCIE | Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial. | 0009-7322 | 14.739 | 2022-08-09 |
최성수 | SCIE | Prediction of Mortality after Burn Surgery in Critically Ill Burn Patients Using Machine Learning Models | 2075-4426 | 2022-08-08 | |
김동관 | SCIE | Long-term outcome of minimally invasive thymectomy versus open thymectomy for locally advanced cases | 1010-7940 | 4.534 | 2022-08-03 |
안진희 | SCIE | Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma | 1078-0432 | 13.801 | 2022-08-02 |
장세진 | SCIE | Data on the evaluation of the relation between β-arrestin 2 and YAP phosphorylation in patient-derived colon cancer organoids | 2352-3409 | 2022-08-02 | |
김송철 | SCIE | The impact of pylorus preservation on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy: A historical cohort study | 1868-6974 | 3.149 | 2022-08-01 |